Clinical Trial Update: Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Pfizer conducted a four-year extension to assess the long-term safety of inhaled insulin in adults with Type 1 or Type 2 diabetes; the Phase 2 trial was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Inhaled insulin (insulin)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus | Phase 2 | Status: TERMINATED | Results posted: 2009-11-09